| Symbol: |
ARPP21
|
| Description: |
cAMP-regulated phosphoprotein, 21kDa [Source:HGNC Symbol;Acc:16968]
|
| Location: |
Chr3:35680437-35835988[+]
|
| CRmiRSNP:
~ Export ~
|
Records:null
| Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
| Compound:
~ Export ~
|
Records:90
| Gene |
Compound |
Gen_sig |
Exp_pattern |
| ARPP21 |
NSC 109834 |
0.014 |
Down |
| ARPP21 |
NSC 113491 |
0.011 |
Down |
| ARPP21 |
Crotonosid |
0.04 |
Down |
| ARPP21 |
Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- |
0.01 |
Up |
| ARPP21 |
NSC 13477 |
0.014 |
Up |
| ARPP21 |
Ethanesulfonic acid, compd. with 2-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]acetanilide (1:1) |
0.019 |
Up |
| ARPP21 |
Benzamide, N-[2-(diethylamino)ethyl]-4-methyl-2-nitro- 3-(phenylmethoxy)- |
0.026 |
Up |
| ARPP21 |
NSC 15795 |
0.027 |
Up |
| ARPP21 |
Pimozide |
0.042 |
Up |
| ARPP21 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.01 |
Up |
| ARPP21 |
NSC 17753 |
0.007 |
Up |
| ARPP21 |
2-Imidazoline-1-ethanol, .alpha.,4,4-trimethyl-2-undecyl- |
0.006 |
Up |
| ARPP21 |
Viridomycin |
0.003 |
Up |
| ARPP21 |
Methanaminium, N-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) |
0.019 |
Up |
| ARPP21 |
NSC 294153 |
0.024 |
Down |
Expression pattern: Sensitivity / Resistance
Total:6 Current:1
[First] [Prev] Next Last
|
| SNP:
~ Export ~
|
Records:22
Total:2 Current:1
[First] [Prev] Next Last
|
| miRNA:
~ Export ~
|
Records:null
| Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|